Nadine MuskatelTungMD

PubMed

• 1 citations
  Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations.
  Kotsopoulos, J., Gronwald, J., Huzarski, T., Møller, P., Pal, T., McCuaig, J., Singer, C., Karlan, B., Aeilts, A., Eng, C., Eisen, A., Bordeleau, L., Foulkes, W., Tung...> ;JAMA Oncology. 2024 Feb 29
• 1 citations
  MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.
  Jan Lubinski, Joanne Kotsopoulos, Pal Moller, Tuya Pal, Andrea Eisen, Larissa Peck, Beth Y Karlan, Amber Aeilts, Charis Eng, Louise Bordeleau, William D Foulkes, Nadin...> ;JAMA Oncology. 2024 Feb 29
• Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
  Kelly Metcalfe, Tomasz Huzarski, Jacek Gronwald, Joanne Kotsopoulos, Raymond Kim, Pal Moller, Tuya Pal, Amber Aeilts, Andrea Eisen, Beth Karlan, Louise Bordeleau, Nadi...> ;British Journal of Cancer. 2024 Feb 1
• 3 citations
  Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing.
  Nadine Tung, Kali Chatham Dougherty, Emily Stern Gatof, Kim DeLeonardis, Lauren Hogan, Hanna Tukachinsky, Erica Gornstein, Geoffrey R Oxnard, Kimberly McGregor, Rachel...> ;NPJ Precision Oncology. 2023 Aug 11
• Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer.
  Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Anneke Lucassen, Nadine M Tung, Claudi...> ;JCO Precision Oncology. 2023 Aug 1
• 4 citations
  Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
  Elżbieta Senkus, Suzette Delaloge, Susan M Domchek, Pierfranco Conte, Seock-Ah Im, Binghe Xu, Anne Armstrong, Norikazu Masuda, Anitra Fielding, Mark Robson, Nadine Tung> ;International Journal of Cancer. 2023 Aug 15
• 3 citations
  Incidence and Prevalence of Intraductal Papillary Mucinous Neoplasms in Individuals With BRCA1 and BRCA2 Pathogenic Variant.
  Ishani Shah, Andy Silva-Santisteban, Katharine A Germansky, Vaibhav Wadhwa, Nadine Tung, Dora C Huang, Cinthana Kandasamy, Jack Mlabasati, Mohammad Bilal, Mandeep S Sa...> ;Journal of Clinical Gastroenterology. 2023 Mar 1
• 13 citations
  OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and...
  Mark E Robson, Seock-Ah Im, Elzbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Nadine Tung, Anne Armstrong, Mike Dymond, Anitra Fielding, ...> ;European Journal of Cancer. 2023 May 1
• Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment.
  D Gareth Evans, Kelly-Anne Phillips, Roger L Milne, Robert Fruscio, Cezary Cybulski, Jacek Gronwald, Jan Lubinski, Tomasz Huzarski, Zerin Hyder, Claire Forde, Kelly Me...> ;British Journal of Cancer. 2023 Feb 1
• 1 citations
  The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
  Kelly A Metcalfe, Jacek Gronwald, Nadine M Tung, Jeanna M McCuaig, Andrea Eisen, Christine Elser, William D Foulkes, Susan L Neuhausen, Leigha Senter, Pal Moller, Loui...> ;Cancer. 2023 Mar 15
• 3 citations
  Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer Treatment.
  Gabrielle B Rocque, Courtney Andrews, Valerie M Lawhon, Rachel Frazier, Stacey A Ingram, Mary Lou Smith, Lynne I Wagner, Lisa Zubkoff, Nadine Tung, Lauren P Wallner, A...> ;JCO Oncology Practice. 2023 Feb 1
• Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Can...
  Junko Tsuji, Tianyu Li, Albert Grinshpun, Tim Coorens, Douglas Russo, Leilani Anderson, Rebecca Rees, Agostina Nardone, Candace Patterson, Niall J Lennon, Carrie Cibul...> ;Clinical Cancer Research. 2022 Dec 1
• 1 citations
  Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
  Dhawan, M. S., Hakkaart, C., Pearson, J., Marquart, L., Dennis, J., Wiggins, G., Barnes, D., Robinson, B., Mace, P., Aittomäki, K., Andrulis, I., Arun, B., Azzollini, ...> ;Communications Biology. 2022 Oct 6
• 11 citations
  Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers.
  Felipe Batalini, Doga C Gulhan, Victor Mao, Antuan Tran, Madeline Polak, Niya Xiong, Nabihah Tayob, Nadine M Tung, Eric P Winer, Erica L Mayer, Stian Knappskog, Per E ...> ;Clinical Cancer Research. 2022 Nov 1
• 3 citations
  Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retr...
  Tal Sella, Pedro Exman, Siyang Ren, Taylor S Freret, Katherine E Economy, Wendy Y Chen, Heather A Parsons, Nancy U Lin, Beverly Moy, Nadine M Tung, Ann H Partridge, Na...> ;Breast Cancer Research and Treatment. 2022 Aug 1
• 3 citations
  Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A Reappraisal.
  Joanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, Janusz Menkiszak, Jeanna McCuaig, Kelly Metcalfe, William D Foulkes, Susan L Neuhausen, Sophie Sun, Beth Y Karlan, An...> ;Cancer Epidemiology, Biomarkers & Prevention. 2022 Jul 1
• 1 citations
  Q and A: A New Standard of Care for Germlineand/orMutation Carriers With Early-Stage Breast Cancer.
  Neelam V Desai, Dana Zakalik, Mark R Somerfield, Nadine M Tung> ;JCO Oncology Practice. 2022 Jun 1
• 14 citations
  A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer.
  Adrienne G Waks, Neelam V Desai, Tianyu Li, Philip D Poorvu, Ann H Partridge, Natalie Sinclair, Laura M Spring, Meredith Faggen, Michael Constantine, Otto Metzger, Jil...> ;NPJ Breast Cancer. 2022 May 10
• Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
  Eileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, Michelle R Jones, Xin Yang, Katja K H Aben, Muriel A Adank, Simona Agata, Irene L Andrulis, Hoda Anton-Culver, Nata...> ;European Journal of Human Genetics. 2022 May 1
• 38 citations
  PARP inhibition in breast cancer: progress made and future hopes.
  Nadine Tung, Judy E Garber> ;NPJ Breast Cancer. 2022 Apr 8
• 4 citations
  Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
  Yue Yin Xia, Jacek Gronwald, Beth Karlan, Jan Lubinski, Jeanna M McCuaig, Jennifer Brooks, Pal Moller, Andrea Eisen, Sophie Sun, Leigha Senter, Louise Bordeleau, Susan...> ;Gynecologic Oncology. 2022 Mar 1
• 16 citations
  Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
  Eileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, Michelle R Jones, Xin Yang, Katja K H Aben, Muriel A Adank, Simona Agata, Irene L Andrulis, Hoda Anton-Culver, Nata...> ;European Journal of Human Genetics. 2022 Mar 1
• 8 citations
  Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TB...
  Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A Yardley, Steven J Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani...> ;NPJ Breast Cancer. 2022 Feb 16
• 5 citations
  Evaluation of TP53 Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic TP53 Variants
  Alison Schwartz, Sophie Hyman, Samantha Stokes, Danielle Castillo, Nadine Tung, Jeffrey N. Weitzel, Huma Q. Rana, Judy Garber> ;JCO Precision Oncology. 2021 Nov 3
• 5 citations
  Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.
  Ciara C. O’Sullivan, Karla V. Ballman, Linda M. McCall, Anuhya Kommalapati, Tyler Zemla, Anna Weiss, Melissa Mitchell, Victoria S. Blinder, Nadine Tung, William J. Irv...> ;Future Oncology. 2021 Oct 12
• Join now to see all